CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort.

Stephanie T JüngerFelipe AndreiuoloMartin MynarekInken WohlersSven RahmannLudger Klein-HitpassEvelyn DörnerAnja Zur MühlenNatalia Velez-CharKatja von HoffMonika Warmuth-MetzRolf-Dieter KortmannBeate TimmermannAndre von BuerenStefan RutkowskiTorsten Pietsch

Published in: Acta neuropathologica (2020)

Keyphrases

study protocol
phase iii
clinical trial
phase ii
randomized controlled trial